Physicochemical Properties
| Molecular Formula | C13H12 |
| Molecular Weight | 168.24 |
| Exact Mass | 168.093 |
| CAS # | 101-81-5 |
| PubChem CID | 7580 |
| Appearance | <24.5°C Powder,>24.5°C Liquid |
| Density | 1.0±0.1 g/cm3 |
| Boiling Point | 264.3±0.0 °C at 760 mmHg |
| Melting Point | 24.5 °C |
| Flash Point | 104.9±9.7 °C |
| Vapour Pressure | 0.0±0.2 mmHg at 25°C |
| Index of Refraction | 1.572 |
| LogP | 4.21 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 13 |
| Complexity | 111 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | CZZYITDELCSZES-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C13H12/c1-3-7-12(8-4-1)11-13-9-5-2-6-10-13/h1-10H,11H2 |
| Chemical Name | benzylbenzene |
| Synonyms | Benzylphenyl |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ADME/Pharmacokinetics |
Metabolism / Metabolites Urine and feces, and two-hour bile samples from adult male rats dosed with (14)C-diphenylmethane were analyzed for benzhydrol and 2- and 4-hydroxydiphenyl-methane by silica gel GF t.l.c. and (14)C-determination. Mean values of 48.4% and 17.7% of the administered (14)C were present in 24 hr urine and feces, respectively. Benzhydrol and 2- and 4-hydroxydiphenylmethane comprised 3.7%, 0.3% and 4.8% respectively of the (14)C isolated from urine and 3.1%, 0.8%, and 4.8% respectively of the (14)C isolated from feces. Bile samples (2 hr) contained 3.2% of the administered radioactivity. After treatment with beta-glucuronidase/aryl sulphatase, 71.9% of the recovered biliary radioactivity was identified as benzhydrol (37.5%) and 4-hydroxydiphenylmethane (34.4%). CONVERSION OF DIPHENYLMETHANE TO P-HYDROXYDIPHENYLMETHANE WAS DEMONSTRATED IN RATS GIVEN 900 MG/KG IP; 24 HR URINE CONTAINED 0.37 MMOL OF UNCONJUGATED & 0.06 MMOL OF CONJUGATED P-HYDROXYDIPHENYLMETHANE. FECES CONTAINED 0.06 MMOL MIXT OF CONJUGATED & UNCONJUGATED. DIPHENYLMETHANE WAS CONVERTED TO P-HYDROXYDIPHENYLMETHANE, DIPHENYLMETHANOL, & DIPHENYL KETONE BY RAT LIVER MICROSOMES. A STRAIN OF HYDROGENOMONAS WAS ISOLATED BY ELECTIVE CULTURE IN A SOLN CONTAINING DIPHENYLMETHANE (DDT ANALOG) AS SOLE CARBON SOURCE. CONSTITUTIVE ENZYMES EFFECTED OXIDATION & FISSION OF ONE BENZENE RING OR DIPHENYLMETHANE, AND PHENYLACETIC ACID WAS FOUND AS A MAJOR DEGRADATION PRODUCT. SMALL AMOUNTS OF PHENYLGLYOXYLIC ACID & BENZOIC ACID WERE ALSO GENERATED. Diphenylmethane is hydroxylated in the rabbit and some 15% of the dose is excreted as 4-hydroxydiphenylmethane, which is largely (80-90%) in the free state. Neither the hydrocarbon nor its metabolite is estrogenic. This reaction also occurs in the dog. |
| References |
[1]. Biochemical reagents[M]//Methods of Enzymatic Analysis. Academic Press, 1965: 967-1037. |
| Additional Infomation | Diphenylmethane is a diarylmethane that is methane substituted by two phenyl groups. |
Solubility Data
| Solubility (In Vitro) | May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples |
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples. Injection Formulations (e.g. IP/IV/IM/SC) Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] *Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline) Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline) Injection Formulation 7: Ethanol : Cremophor : Saline = 10： 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline) Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil) Injection Formulation 10: EtOH : PEG300：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Oral Formulations Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). Oral Formulation 3: Dissolved in PEG400 Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose Oral Formulation 6: Mixing with food powders Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.9439 mL | 29.7194 mL | 59.4389 mL | |
| 5 mM | 1.1888 mL | 5.9439 mL | 11.8878 mL | |
| 10 mM | 0.5944 mL | 2.9719 mL | 5.9439 mL |